1-ethyl-3-methyl-6-[5-(2-methyl-1,3-thiazol-4-yl)-2-propoxyphenyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one
C21H23N5O2S — CID 135415122
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-ethyl-3-methyl-6-[5-(2-methyl-1,3-thiazol-4-yl)-2-propoxyphenyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one
1-ethyl-3-methyl-6-[5-(2-methyl-1,3-thiazol-4-yl)-2-propoxyphenyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one (PubChem CID 135415122) has the molecular formula C21H23N5O2S and a molecular weight of 409.52 g/mol. Its IUPAC name is 1-ethyl-3-methyl-6-[5-(2-methyl-1,3-thiazol-4-yl)-2-propoxyphenyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one.
Molecular Properties
| Compound Name | 1-ethyl-3-methyl-6-[5-(2-methyl-1,3-thiazol-4-yl)-2-propoxyphenyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
|---|---|
| PubChem CID | 135415122 |
| Molecular Formula | C21H23N5O2S |
| Molecular Weight | 409.52 g/mol |
| Exact Mass | 409.16 |
| IUPAC Name | 1-ethyl-3-methyl-6-[5-(2-methyl-1,3-thiazol-4-yl)-2-propoxyphenyl]-5H-pyrazolo[5,4-d]pyrimidin-4-one |
| SMILES | CCCOc1ccc(-c2csc(C)n2)cc1-c1nc2c(c(C)nn2CC)c(=O)[nH]1 |
| InChI | InChI=1S/C21H23N5O2S/c1-5-9-28-17-8-7-14(16-11-29-13(4)22-16)10-15(17)19-23-20-18(21(27)24-19)12(3)25-26(20)6-2/h7-8,10-11H,5-6,9H2,1-4H3,(H,23,24,27) |
| InChIKey | KIFAWCZUBQDIFK-UHFFFAOYSA-N |
| XLogP | 4.34 |
| TPSA | 85.69 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.52 |
| LogP ≤ 5 | 4.34 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135415122 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.